1.          Introduction

1.1        Study Scope

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        US Dermatology OTC Medications Market – By Product Type

1.3.2        US Dermatology OTC Medications Market – By Indication

1.3.3        US Dermatology OTC Medications Market – By Route of Administration

1.3.4        US Dermatology OTC Medications Market – By Distribution Channel

2.          Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          US Dermatology OTC Medications Market Landscape

4.1        Market Overview

4.2        PEST Analysis

4.2.1        US: PEST Analysis

4.3        Expert Opinion

5.          US Dermatology OTC Medications Market – Key Market Dynamics

5.1        Market Drivers

5.1.1        Rising Prevalence of Skin Abnormalities

5.1.2        Increasing Availability of Dermatology Medication Over the Counter (OTC)

5.2        Market Restraints

5.2.1        Side Effects Associated with OTC Dermatology Medication

5.3        Market Opportunities

5.3.1        Growing OTC Market

5.4        Future Trends

5.4.1        Rising Adoption of Telemedicine

5.5        Impact Analysis

6.          Dermatology OTC Medications– US Market Analysis

6.1        US Dermatology OTC Medications Market Overview

6.2        Market Positioning of Key Players

7.          US Dermatology OTC Medications Market Analysis– Product Type

7.1        Overview

7.2        US Dermatology OTC Medications Market, by Product Type 2020 & 2028 (%)

7.3        Tablets and Capsules

7.3.1        Overview

7.3.2        US Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ Mn)

7.4        Oils

7.4.1        Overview

7.4.2        US Oils Market Revenue and Forecasts to 2028 (US$ Mn)

7.5        Gels

7.5.1        Overview

7.5.2        US Gels Market Revenue and Forecasts to 2028 (US$ Mn)

7.6        Creams and Ointments

7.6.1        Overview

7.6.2        Creams and Ointments Market Revenue and Forecasts to 2028 (US$ Mn)

7.7        Others

7.7.1        Overview

7.7.2        Others Market Revenue and Forecasts to 2028 (US$ Mn)

8.          US Dermatology OTC Medications Market Analysis – Indication

8.1        Overview

8.2        US Dermatology OTC Medications Market, By Indication 2020 & 2028 (%)

8.3        Dermatitis

8.3.1        Overview

8.3.2        US Dermatitis Market Revenue and Forecasts to 2028 (US$ Mn)

8.4        Acne

8.4.1        Overview

8.4.2        US Acne Market Revenue and Forecasts to 2028 (US$ Mn)

8.5        Psoriasis

8.5.1        Overview

8.5.2        US Psoriasis Market Revenue and Forecasts to 2028 (US$ Mn)

8.6        Skin Bleaching

8.6.1        Overview

8.6.2        US Skin Bleaching Market Revenue and Forecasts to 2028 (US$ Mn)

8.7        Anti-Fungal

8.7.1        Overview

8.7.2        US Anti-Fungal Market Revenue and Forecasts to 2028 (US$ Mn)

8.8        Wart Remover

8.8.1        Overview

8.8.2        US Wart Remover Market Revenue and Forecasts to 2028 (US$ Mn)

8.9        Others

8.9.1        Overview

8.9.2        US Others Market Revenue and Forecasts to 2028 (US$ Mn)

9.          US Dermatology OTC Medications Market Analysis – Route of Administration

9.1        Overview

9.2        US Dermatology OTC Medications Market, By Route of Administration 2020 & 2028 (%)

9.3        Topical

9.3.1        Overview

9.3.2        US Topical Market Revenue and Forecasts to 2028 (US$ Mn)

9.4        Oral

9.4.1        Overview

9.4.2        US Oral Market Revenue and Forecasts to 2028 (US$ Mn)

10.       US Dermatology OTC Medications Market Analysis – Distribution Channel

10.1      Overview

10.2      US Dermatology OTC Medications Market, By Distribution Channel 2020 & 2028 (%)

10.3      Online Distribution

10.3.1     Overview

10.3.2     US Online Distribution Market Revenue and Forecasts to 2028 (US$ Mn)

10.4      Hospital and Retail Pharmacies

10.4.1     Overview

10.4.2     US Hospital and Retail Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

10.5      Super and Hyper Markets

10.5.1     Overview

10.5.2     US Super and Hyper Markets Market Revenue and Forecasts to 2028 (US$ Mn)

11.       Impact of COVID-19 Pandemic on US Dermatology OTC Medications Market

11.1      US: Impact Assessment of COVID-19 Pandemic

12.       US OTC Dermatology Medications Market– Industry Landscape

12.1      Overview

13.       Company Profiles

13.1      Bausch Health Companies Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Perrigo Company plc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Viatris Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      LEO Pharma A/S

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      GlaxoSmithKline plc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Galderma

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Dr. Reddy's Laboratories

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   ACELLA PHARMACEUTICALS, LLC

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.       Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.            Inorganic Developments Done by Companies

Table 2.            Glossary of Terms, US OTC Dermatology Medications Market

LIST OF FIGURES

Figure 1.           US Dermatology OTC Medications Market Segmentation

Figure 2.           US Dermatology OTC Medications Market Overview

Figure 3.           Creams and Ointments Segment by Product Type is Expected to Show Remarkable Growth During Forecast Period

Figure 4.           US: PEST Analysis

Figure 5.           Expert Opinion

Figure 6.           US Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints

Figure 7.           Overview of US Dermatology OTC Medications Market

Figure 8.           Market Positioning of Key Players in US Dermatology OTC Medications Market

Figure 9.           US Dermatology OTC Medications Market, By Product Type 2020 & 2028 (%)

Figure 10.        US Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        US Oils Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        US Gels Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        US Creams and Ointments Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        US Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        US Dermatology OTC Medications Market, by Indication 2020 & 2028 (%)

Figure 16.        US Dermatitis Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        US Acne Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        US Psoriasis Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        US Skin Bleaching Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        US Anti-Fungal Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        US Wart Remover Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        US Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        US Dermatology OTC Medications Market, by Route of Administration 2020 & 2028 (%)

Figure 24.        US Topical Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        US Oral Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        US Dermatology OTC Medications Market, by Distribution Channel 2020 & 2028 (%)

Figure 27.        US Online Distribution Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        US Hospital and Retail Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        US Super and Hyper Markets Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30.        Impact of COVID-19 Pandemic on OTC Dermatology Medications in the US